You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy

 

Online download statistics by month:

Online download statistics by month: July 2021 to September 2025

AbstractFullPdf
Jul 202118718746
Aug 2021286286103
Sep 202110610747
Oct 202110810832
Nov 2021939337
Dec 2021767618
Jan 2022414210
Feb 2022303319
Mar 2022545538
Apr 2022454617
May 2022333421
Jun 2022383912
Jul 2022303010
Aug 2022383817
Sep 2022313157
Oct 2022474920
Nov 202230308
Dec 2022202010
Jan 2023323215
Feb 2023555515
Mar 2023343733
Apr 2023212125
May 2023181811
Jun 202324246
Jul 2023151511
Aug 2023444412
Sep 2023222213
Oct 202319193
Nov 202331316
Dec 2023212215
Jan 2024293011
Feb 2024222412
Mar 2024333326
Apr 2024252526
May 2024202014
Jun 2024282712
Jul 2024384020
Aug 2024333413
Sep 2024212112
Oct 2024393918
Nov 202437389
Dec 2024323313
Jan 2025424224
Feb 2025181813
Mar 2025333322
Apr 2025424222
May 2025303013
Jun 2025192010
Jul 2025110
Sep 2025110
Total21722195977